insulin Archives -

Sanofi extends Health2Sync digital diabetes partnership to Japan

Phil Taylor Diabetes, digital, digital health, Health2Sync, insulin, partnering, Sanofi 0 Comment

Digital health company Health2Sync will work with Sanofi on digitising its range of insulin products in Japan, extending

Sanofi extends Health2Sync digital diabetes partnership to Japan

https://pharmaphorum.com/news/sanofi-extends-health2sync-digital-diabetes-partnership-to-japan/

News/ News/ Sales and Marketing

Insulin producers face fresh lawsuit in US over pricing

Phil Taylor Drug pricing, Eli Lilly, insulin, litigation, Novo Nordisk, Sanofi 0 Comment

Arkansas has become the latest US state to issue a legal challenge to the big three insulin producers

Insulin producers face fresh lawsuit in US over pricing

https://pharmaphorum.com/news/insulin-producers-face-fresh-lawsuit-in-us-over-pricing/

News/ News/ R&D

Novo Nordisk once-weekly insulin clears first phase 3 test

Phil Taylor Diabetes, drug delivery, insulin, insulin icodec, metabolic disease, Novo Nordisk 0 Comment

For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact

Novo Nordisk once-weekly insulin clears first phase 3 test

https://pharmaphorum.com/news/novo-nordisk-once-weekly-insulin-clears-first-phase-3-test/

Market Access/ Views and analysis

Why the drug pricing debate is focused on insulin

Ben Hargreaves Diabetes, Drug pricing, insulin, pharma, PhRMA 0 Comment

The treatment has been around for over a century but insulin has still become the centre of the

Why the drug pricing debate is focused on insulin

https://pharmaphorum.com/views-and-analysis/why-the-drug-pricing-debate-is-focused-on-insulin/

Market Access/ Views & Analysis/ Views and analysis

What is the solution to America’s deepening access to medicines crisis?

Amanda Barrell America, insulin, Joe Biden, Pharmaceutical Research and Manufacturers of America 0 Comment

Last week, a bill to limit the cost of insulin in the US passed the House of Representatives,

What is the solution to America’s deepening access to medicines crisis?

https://pharmaphorum.com/market-access-2/what-is-the-solution-to-americas-deepening-access-to-medicines-crisis/

News/ News/ Sales and Marketing

Insulin price caps on the horizon as Senate leader plans vote

Phil Taylor Diabetes, Drug pricing, insulin, legislation, US 0 Comment

The US Senate will vote in the coming weeks on whether to introduce a $35 cap on the

Insulin price caps on the horizon as Senate leader plans vote

https://pharmaphorum.com/news/insulin-price-caps-on-the-horizon-as-senate-leader-plans-vote/

News/ News/ Sales and Marketing

Civica plans shake-up of insulin sector with low-cost biosimilars

Phil Taylor biosimilar, Civica, Eli Lilly, insulin, Novo Nordisk, pricing, Sanofi 0 Comment

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US

Civica plans shake-up of insulin sector with low-cost biosimilars

https://pharmaphorum.com/news/civica-plans-shake-up-of-insulin-sector-with-low-cost-biosimilars/

Digital/ News/ News

Novo Nordisk launches first smart insulin pens for NHS patients

Phil Taylor insulin, NHS, Novo Nordisk, patients, smart insulin pen, UK 0 Comment

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS

Novo Nordisk launches first smart insulin pens for NHS patients

https://pharmaphorum.com/news/novo-nordisk-launches-first-smart-insulin-pens-for-nhs-patients/

News/ News/ Sales and Marketing

China’s insulin plans will hit 2022 revenues, says Novo Nordisk

Phil Taylor China, insulin, Novo Nordisk, Value-based pricing 0 Comment

Novo Nordisk has said that the introduction of value-based procurement (VBP) for insulin products by the Chinese government

China’s insulin plans will hit 2022 revenues, says Novo Nordisk

https://pharmaphorum.com/news/chinas-insulin-plans-will-hit-2022-revenues-says-novo-nordisk/

Trending

insulin

Login